Gasteyger C - Search Results

1

Center-size as a predictor of weight-loss outcome in multicenter trials including a low-calorie diet.

Gasteyger C, Christensen R, Larsen TM, Vercruysse F, Toubro S, Astrup A. Gasteyger C, et al. Obesity (Silver Spring). 2010 Nov;18(11):2160-4. doi: 10.1038/oby.2010.118. Epub 2010 Jun 10. Obesity (Silver Spring). 2010. PMID: 20539303 Free article. Clinical Trial.

2

Visceral fat loss induced by a low-calorie diet: a direct comparison between women and men.

Gasteyger C, Larsen TM, Vercruysse F, Pedersen D, Toubro S, Astrup A. Gasteyger C, et al. Diabetes Obes Metab. 2009 Jun;11(6):596-602. doi: 10.1111/j.1463-1326.2008.01025.x. Epub 2009 Apr 5. Diabetes Obes Metab. 2009. PMID: 19383030 Clinical Trial.

3

Effect of a dietary-induced weight loss on liver enzymes in obese subjects.

Gasteyger C, Larsen TM, Vercruysse F, Astrup A. Gasteyger C, et al. Am J Clin Nutr. 2008 May;87(5):1141-7. doi: 10.1093/ajcn/87.5.1141. Am J Clin Nutr. 2008. PMID: 18469232 Free article. Clinical Trial.

4

A critical review of the cannabinoid receptor as a drug target for obesity management.

Akbas F, Gasteyger C, Sjödin A, Astrup A, Larsen TM. Akbas F, et al. Among authors: gasteyger c. Obes Rev. 2009 Jan;10(1):58-67. doi: 10.1111/j.1467-789X.2008.00520.x. Epub 2008 Aug 20. Obes Rev. 2009. PMID: 18721231 Review.

5

The effect of tesofensine on appetite sensations.

Gilbert JA, Gasteyger C, Raben A, Meier DH, Astrup A, Sjödin A. Gilbert JA, et al. Among authors: gasteyger c. Obesity (Silver Spring). 2012 Mar;20(3):553-61. doi: 10.1038/oby.2011.197. Epub 2011 Jun 30. Obesity (Silver Spring). 2012. PMID: 21720440 Free article. Clinical Trial.

6

The effect of the triple monoamine reuptake inhibitor tesofensine on energy metabolism and appetite in overweight and moderately obese men.

Sjödin A, Gasteyger C, Nielsen AL, Raben A, Mikkelsen JD, Jensen JK, Meier D, Astrup A. Sjödin A, et al. Among authors: gasteyger c. Int J Obes (Lond). 2010 Nov;34(11):1634-43. doi: 10.1038/ijo.2010.87. Epub 2010 May 18. Int J Obes (Lond). 2010. PMID: 20479765 Clinical Trial.

7

Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation.

Gasteyger C, Suter M, Gaillard RC, Giusti V. Gasteyger C, et al. Am J Clin Nutr. 2008 May;87(5):1128-33. doi: 10.1093/ajcn/87.5.1128. Am J Clin Nutr. 2008. PMID: 18469230 Free article.

8

Gastric banding induces negative bone remodelling in the absence of secondary hyperparathyroidism: potential role of serum C telopeptides for follow-up.

Giusti V, Gasteyger C, Suter M, Heraief E, Gaillard RC, Burckhardt P. Giusti V, et al. Among authors: gasteyger c. Int J Obes (Lond). 2005 Dec;29(12):1429-35. doi: 10.1038/sj.ijo.0803040. Int J Obes (Lond). 2005. PMID: 16077715

9

[Nutritional follow-up after gastric bypass].

Gasteyger C, Giusti V. Gasteyger C, et al. Rev Med Suisse. 2006 Mar 29;2(59):844-7. Rev Med Suisse. 2006. PMID: 16646366 French.

10

Changes in body composition, metabolic profile and nutritional status 24 months after gastric banding.

Gasteyger C, Suter M, Calmes JM, Gaillard RC, Giusti V. Gasteyger C, et al. Obes Surg. 2006 Mar;16(3):243-50. doi: 10.1381/096089206776116381. Obes Surg. 2006. PMID: 16545153

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters